Evaluating vaccines and treatments for respiratory viruses using cotton rats.
Task A88: Cotton Rat Model for the Evaluation of Vaccines and Therapeutics for RSV and Related Viruses
This study is looking at how well new vaccines and treatments for respiratory syncytial virus (RSV) work by testing them on cotton rats first, so we can make sure they're safe and effective for people later on.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sigmovir Biosystems, INC. NIH-funded |
| Lab location | 1 site (Rockville, United States) |
| Project ID | NIH-11250878 on NIH RePORTER |
What this research studies
This research focuses on developing and refining models using cotton rats to evaluate vaccines and therapeutic agents for respiratory syncytial virus (RSV) and related viruses. By using these animal models, researchers aim to test the effectiveness and safety of potential vaccines and treatments before they are used in humans. The approach involves careful monitoring of the cotton rats' responses to various candidate vaccines and therapies, providing valuable insights into their potential effectiveness in humans.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research would be individuals at high risk for RSV infections, such as infants, elderly adults, and those with compromised immune systems.
Not a fit: Patients who are not at risk for RSV or related respiratory viruses may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines and treatments for RSV and similar respiratory viruses, improving patient outcomes.
How similar studies have performed: Previous research using animal models for vaccine evaluation has shown success in developing effective vaccines for various infectious diseases, indicating a promising approach.
Where this research is happening
Rockville, United States
- Sigmovir Biosystems, INC. — Rockville, United States (Active)
Researchers
- Principal investigator: Hauschild, Steve — Sigmovir Biosystems, INC.
- Study coordinator: Hauschild, Steve
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.